MorphoSys AG Reports Fourth Quarter and Full Year 2021 Finan

DGAP-News: MorphoSys AG


/ Key word: Annual Report





MorphoSys AG Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update






16.03.2022 / 21:01



The... | March 16, 2022

Related Keywords

Germany , Boston , Massachusetts , United States , Canada , United Kingdom , Planegg , Bayern , American , German , Thomas Biegi , Julia Neugebauer , Jean Paul Kress , Myles Clouston , Jeanette Bressi , American Society Of Hematology Annual Meeting , Xencor Inc , Linkedin , Twitter , Nasdaq , Morphosys Group Key Figures , Meeting Of The American Society Nephrology , Constellation Pharmaceuticals , National Comprehensive Cancer Network , Mother Program , Development Funding Bonds , Drug Administration , European Commission , Us Communications , Exchange Commission , Development Rd Expenses , Health Canada , Fourth Quarter , Full Year , Provides Corporate , Chief Executive Officer , Paul Kress , American Society , Hematology Annual Meeting , Monjuvi On March , Clinical Practice Guidelines , Program Highlights , Royalty Pharma , Royalty Pharma Investments , Net Profit , Sys Group Key Figures , Tax Benefit , Financial Statements , Antibody Dependent Cell Mediated Cytotoxicity , Antibody Dependent Cellular Phagocytosis , Morphosy Annual Report , Morphosys Ag Stock Exchange , News , Information , Press Release , Morphosys , Key , Nnual , G , Reports , Fourth , Quarter , End , Bull , Ear , 021 , Financial , Results , Rovides , Corporate , Pdate Mor De0006632003 ,